It advised the public to remain calm and said people who were recovering from recent severe illness should consider delaying getting the vaccine.
Botswana's investigation comes after Europe's drug regulator said it had found a possible link between AstraZeneca's vaccine and very rare cases of blood clots. Experts say that, even if a causal link is proved between the vaccine and blood clots, the risks of getting a serious clot are minute compared to the risks from possible Covid-19 infection, which can cause similar clots along with other serious symptoms.
Botswana has recorded around 40,000 coronavirus cases and 630 deaths during the pandemic, few by comparison with many other countries around the world, but its diamond-driven economy was hit hard last year, contracting almost 8%. AstraZeneca's shot is the cheapest and most readily available. It does not need to be kept at extremely cold temperatures unlike some other vaccines, making it a mainstay of many vaccination programmes in the developing world.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.